In a recent study conducted at a major London emergency department, researchers identified significant discrepancies between self-reported drug use and laboratory-detected substances in patients presenting with acute drug toxicity. This research, which evaluated nearly 1,000 patients, sheds light on the limitations of self-reported drug histories in emergency settings and highlights the need for a more nuanced approach to patient care during drug-related admissions. The findings were published in the journal Clinical Toxicology.
Conducted over a one-year period from 2019 to 2020, the study observed a cohort of patients presenting with symptoms of acute recreational drug or new psychoactive substance (NPS) toxicity. Emergency department staff recorded patients’ self-reports, which included both personal accounts and information provided by on-scene bystanders or first responders. Subsequently, researchers used high-resolution mass spectrometry to analyse serum samples from each patient, revealing that certain drugs – especially opioids and benzodiazepines – were frequently detected despite being unreported.
Among the findings, self-reported accuracy varied widely depending on the type of substance involved. While opioids were correctly reported by patients with a high degree of accuracy, the presence of benzodiazepines and certain NPSs was often underestimated or unmentioned. These discrepancies suggest that many individuals may not be fully aware of what they have ingested, potentially due to polysubstance use, confusion, or intentional concealment.
Interestingly, the study found that patients were more accurate in indicating substances they had not used, compared to their reliability in reporting what they had consumed. This difference highlights the complexity of treating drug toxicity cases in emergency settings, where healthcare professionals must make quick decisions based on incomplete information.
In particular, opioids posed an analytical challenge. Although patients often underreported the use of prescription opioids, laboratory results frequently detected opioids like methadone and codeine, likely stemming from over-the-counter or prescription sources. This underreporting aligns with previous research on drug reporting inaccuracies, where legal, non-recreational medications are often overlooked by patients during self-reports.
The researchers emphasise that while self-reported drug histories can provide valuable initial guidance, laboratory confirmation remains essential for a comprehensive understanding of a patient’s exposure. The study’s findings also underscore the importance of integrating laboratory analysis into routine care, especially in cases involving complex or unpredictable substances.
